{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"30.780","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2025","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"73,598,888","primaryexch":"HKEX","ric":"3880.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BR0ZLP5","am":"6.46","iv":"","ew_strike":"","as":"30.800","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"30.600","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-26 10:38:37.0","lo52":"28.100","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Xu Qi","underlying_ric":"3880.HK","hi52":"41.720","issuer_name":"Medtide Inc. - H Shares","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"29.380","mkt_cap":"2.25","f_aum_hkd":null,"ew_sub_per_to":"","ls":"30.600","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-0.060","aum":"","issued_shares_class_B":null,"vo":"215.70","secondary_listing_flag":false,"listing_date":"30 Jun 2025","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Medtide Inc. - H Shares","nm_s":"MEDTIDE","sym":"3880","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.","op":"30.680","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Room 501-11, Building 6<br/>Yinhai Kechuang Center<br/>Xiasha St, Qiantang District<br/>Hangzhou, Zhejiang, PRC","pc":"-0.20","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"30.660","isin":"CNE100006S86","moneyness":""}},"qid":"1758890442795"}
